How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in ...

The poor translatability of early-stage preclinical models is a major setback in oncology drug development, and inter patient tumor heterogeneity is also a significant hurdle. Patient-derived ...

Three-dimensional (3D) surface geometry provides essential information in various sciences and precision engineering. Fringe Projection Profilometry (FPP) is one of the most powerful non-contact (thus ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA) (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the ...

Dr. Suruchi Kothari, BSc, MD, MRCGP, MSx: Health tech innovator reshaping clinical care. Driven by a tech-forward, patient-centric approach. Cancer's shadow stretches wider than ever, mirroring a ...

Natera NTRA recently announced a collaboration with NVIDIA NVDA to speed up the development of its multimodal AI foundation model platform and broaden its use across precision care. Natera will ...

The center has received 139 submissions for disease modeling, encompassing 191 genetic variants. Half of our submissions are from individuals or programs not affiliated with Baylor College of Medicine ...